Business
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
At #SNMMI24, GE HealthCare expands its technology with the addition of a MINItrace Magni,i designed to be a small footprint cyclotron for reliable, in-house
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\n\nAt #SNMMI24, GE HealthCare expands its technology with the addition of a MINItrace Magni,i designed to be a small footprint cyclotron for reliable, in-house production of commercial PET tracers and radiometals; Omni Legend 21 cm, ii a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands across care areas; and Clarify DL,iii a new deep learning reconstruction technology designed to deliver clear, accurate, and effortless imaging\n\n\n\nCombined with GE HealthCare’s well-established portfolio – including portable systems to reach remote populations and refurbished medical equipment to help improve access to affordable, quality healthcare – these technologies and the Company’s recently acquired MIM Software solutions aim to expand global access to precision care\n\n\n\n TORONTO & CHICAGO--(BUSINESS WIRE)--\nGE HealthCare once again joins the world’s top medical and academic institutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting to discuss today’s healthcare landscape and announce new precision care tools to meet providers’ most pressing needs – namely the accessibility of technologies and solutions for the global practice of personalized medicine.\n\n\nMore than half of the world’s population is underserved and lacks access to essential health services,iv and two-thirds have no access to diagnostic imaging.v Yet even those who have these services and systems within reach may struggle to receive necessary scans due to the challenges healthcare providers often face in reliably sourcing commercial PET tracers – leaving many patients and medical centers around the world without recourse. These shortfalls, in addition to ongoing healthcare resource and staff shortages,vi challenge the adoption of precision care globally.\n\n\n“It’s not enough to develop cutting-edge solutions if they aren’t also made more accessible to clinicians and patients around the world,” shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. “While there is still much work to be done, we are proud to offer a variety of technologies that can evolve with healthcare system needs and help support a patient’s entire care journey – from the systems required to create the radiotracers used to diagnose and monitor disease, to the imaging equipm...